An Antiphospholipid Antibody Profile as a Biomarker for Thrombophilia in Systemic Lupus Erythematosus

Despite recent advances in treatment and significant improvements in prognosis, thrombosis remains the major cause of death in systemic lupus erythematosus (SLE). Antiphospholipid antibodies (aPL) are the main triggers of thrombosis in patients with SLE, with a frequency of approximately 30–40%. Lup...

Descripción completa

Detalles Bibliográficos
Autores principales: Hisada, Ryo, Atsumi, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135455/
https://www.ncbi.nlm.nih.gov/pubmed/37189365
http://dx.doi.org/10.3390/biom13040617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135455/
https://www.ncbi.nlm.nih.gov/pubmed/37189365
http://dx.doi.org/10.3390/biom13040617

Ejemplares similares